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Objectives: The etiology of intrahepatic cholestasis of pregnancy (ICP) involves environmental, hormonal and genetic 
factors. It is thought that ICP may be related to the polymorphic variants of several genes involved in the metabolism and 
transport of bile acids (BA). The goal of our study was to evaluate the possible role of genetic polymorphic variants of ABC 
transporters in patients with ICP. 
Material and methods: 96 women with ICP (mean age of 30.42 years, mean gestational age of 36.83 gestation weeks) and 
211 healthy pregnant women (mean age of 30.68 years, mean gestational age of 39.05 gestation weeks) were enrolled in 
the study. Genetic analysis was performed using a polymerase chain reaction / restriction fragment length polymorphism 
(PCR/RFLP) method. The following polymorphisms were analysed: 1331T > C (V444A) ABCB11 and 1954A > G (R652G) ABCB4.
Results: Our analysis of frequency of genotypes and alleles of the 1954A > G ABCB4 polymorphism revealed no significant 
differences between the ICP and control groups. For the 1331T > C polymorphism of the ABCB11 gene the results revealed 
a higher frequency of 1331CC genotypes in the ICP group (39.58% vs. 29.38%. OR = 1.57, p = 0.05). Also, the frequency 
of the 1331C allele was higher in the ICP group compared to the control group (64.06% vs. 55.69%, OR = 1.42, p = 0.03).
Conclusions: The overrepresentation of mutated variants of the 1331T > C ABCB11 polymorphism in the ICP group suggests 
its contribution to the etiology of the intrahepatic cholestasis of pregnancy. Analysis of genotypes’ co-existence pointed 
to the possibility of the mutated variants of polymorphism 1954A > G ABCB4 and 1331T > C ABCB11 having a summation 
effect on the development of ICP.
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INTRODUCTION
Intrahepatic cholestasis of pregnancy (ICP) is an obstetri-
cal complication, which affects about 1.5% of pregnancies 
among Caucasians. The condition is quite serious since it 
may lead to intrauterine fetal demise. The relevant process 
behind ICP is the excessive accumulation of bile acids in 
hepatocytes and the inhibition of bile excretion [1]. Over-
production of bile acids or their impaired removal from 
hepatocytes may be the reason of this pathology, which 
leads to increased bile acid serum concentration [2–4].
Some of the studies show that polymorphic variants of 
genes encoding ABC transporting proteins may play a role 
in the etiology of ICP. An ABCB11 gene encodes an ABC 
transporter named Bile Salt Export Pump (BSEP) that is re-
sponsible for the removal of bile acids from hepatocytes [5]. 
The degree of the impairment of bile acid transport by BSEP 
depends on the polymorphic variants of ABCB11 gene. 
The gene is localized on chromosome 2, region q31.1 and 
consists of 28 exons. According to the literature, the most fre-
quent Caucasian-specific single nucleotide polymorphism 
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in the ABCB11 gene is 1331T > C (rs2287622). The transition 
of thymine into cytosine translates into alanine in place of 
valine at the position 444 of the protein sequence [6, 7].
Another potent phospholipid transporter is involved in 
bile shuttling, namely a Multidrug Resistance Protein 3 (MDR3). 
The MDR3 protein is encoded by ABCB4 gene [8, 9]. It is found 
on chromosome 7, position 7q21.12 [10, 11]. One of the most 
frequently analyzed ABCB4 gene polymorphism is 1954A > G 
in exon 16 (rs2230028). The result of transition of adenine into 
guanine results in substitution of arginine with glycine at the 
position 652 of protein sequence (R652G, Arg652Gly).
Both BSEP and MRD3 are a part of MDR/TAP protein 
family composed of ATP-active membrane transporters ABC. 
ABC proteins transport many different molecules through 
the cellular membrane and a reduction of its expression 
may lead to excessive accumulation of toxic metabolites 
within cells [12–14].
There are some observations suggesting that hereditary 
impairment of ABCB4 and ABCB11 gene products due to 
gene polymorphism may be a reason of hepatic cirrhosis in 
early childhood [15, 16]. Thus, the dysfunctional ABCB4 and 
ABCB11 genes may also be responsible for the develop-
ment of ICP.
The aim of the study was to explore the possible role 
of gene variants encoding ABCB-type transporters in the 
etiology of ICP. The frequency of single nucleotide polymor-
phism was analyzed in two genes that encode the export 
pumps of bile acid salts: ABCB 11 (BESEP) (1331T > C, V444A 
polymorphism) and ABCB4 (MDR3) (1954A > G, R652G poly-
morphism).
MATERIAL AND METHODS 
A total of 96 women with ICP diagnosed in the second 
half of pregnancy (mean age 30.42 ± 4.38 years, mean ges-
tational age 36.83 ± 2.75 gw.) and 211 healthy pregnant 
women (mean age 30.68 ± 4.67 years, mean gestational 
age 39.05 ± 1.22 gw.) were enrolled into the study. The 
analysis was performed at the Division of Perinatology and 
Women’s Diseases of Poznan University of Medical Sciences 
in Poznan and at the Department of Gynecology and Obstet-
rics with Gynecological Oncology Subdivision of Regional 
Hospital in Zielona Góra in the years 2013–2017 (Poznan Uni-
versity of Medical Sciences Bioethics Committee permission 
no 842/13). All subjects were informed about the goal of the 
study and gave their written consent.
The ICP was diagnosed on the basis of clinical and 
biochemical criteria such as: typical itching without rush, 
fasting total bile acids (TBA) serum concentration higher 
than 10 µmol/L, increased concentration of aminotrans-
ferase (ALT, AST), symptoms subside within 2–3 weeks after 
delivery. The exclusion criteria were as follows: infection 
with hepatitis virus type A, B or C, autoimmune diseases, 
excessive alcohol drinking, HIV infection and all kinds of 
hepatic impairments and dermatological diseases that are 
connected with itching. All women were Caucasian race, 
Polish origin with singleton pregnancy.
The following records were taken of all the patients from 
both groups (ICP and control group): detailed obstetrical 
history, age, gestational age at the delivery, height, weight 
prior to and at the end of pregnancy, systolic and diastolic 
blood pressure, mode of delivery and the newborn condi-
tion. All lab tests were performed at the Central Laboratory 
of Gynecological-Obstetrical Hospital of Poznan University 
of Medical Sciences.
Genomic DNA was extracted using QIAamp DNA Blood 
Mini Kit (Qiagen, Germany) according to the manufacturer’s 
recommendations. Genotyping was performed at the Labo-
ratory of Molecular Biology of Poznan University of Medical 
Sciences using polymerase chain reaction and restriction frag-
ment length polymorphism (PCR/RFLP) method with primers 
published by Dias [17] and Bronsky et al. [18] (Tab. 1). The 
obtained DNA fragments were hydrolyzed with the following 
restriction enzymes: BsuRI for ABCB11 and TspRI for ABCB4.
The observed results and clinical data of patients and 
newborns were analyzed statistically with R software (ver-
sion 3.4.2, http://cran.r‐project.org) and p  <  0.05 was con-
sidered statistically significant.
RESULTS
Analysis of clinical and laboratory data
The analysis of both ICP and control groups has revealed 
some statistically significant differences in the duration of 
pregnancy (36.83 ± 2.75 gw. in ICP group vs. 39.05 ± 1.22 gw. 
in controls, p < 0.0001). Weight gain throughout preg-
nancy was lower in the ICP group compared to controls 
(4.21 ± 1.98 vs. 5.42 ± 1.74, p < 0.0001). Also, the ICP group 
had a statistically significant (p < 0.0001) lower body 
mass of newborns and a slightly lower 5th minute Ap-
gar score compared to the controls (3083.00 ± 634.95 g 
vs. 3425.00 ± 433.82 and 9.74 ± 0.75 vs. 9.97 ± 0.23 respec-
tively). The interesting observation made was a lower pla-
cental mass in the ICP group compared to the controls 
(579.11 ± 150.93 g vs. 620.18 ± 111.37 g, p = 0.02). The other 
values: first minute Apgar score or arterial and venous pH 
values were not statistically different between the groups.
Table 1. Primer sequences used for PCR analysis
SNP Primers for PCR amplification PCR product
ABCB11
1331T > C
5’- ACT TCT Tgg TCA Tgg CTC TCA g -3’
5’-ACT TgA TCT gCA ATg CCA AC-3’ 723 bp
ABCB4
1954A > G
5’- TCC TTg ATT gAg AAg Cag TTA gg-3’
5’- CAA AgA gTA Tgg CTC ATA gTA gC -3’ 457 bp
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Analysis of 1331T > C ABCB11  
and 1954A > G ABCB4 polymorphism
The genetic comparison of the ICP and the control 
group regarding the 1331T > C ABCB11 polymorphism has 
shown a similar frequency of homozygote 1331TT genotype 
(11.46% vs. 18.01% respectively, OR = 0.59, p = 0.10) and of 
heterozygote 1331TC genotype (48.96% vs. 52.61% respec-
tively, OR = 0.86, p = 0.32). A mutated homozygote 1331CC 
genotype was more frequent in the ICP group when com-
pared to the controls (39.58% vs 29.38%, OR = 1.57, p = 0.05). 
The frequency of a wild-type 1331T allele was higher 
in the control group (35.94% vs. 44.31%, p = 0.03), whereas 
the frequency of a mutated 1331C allele was higher in the 
ICP group (64.06% vs. 55.69%, OR = 1.42, p = 0.03) (Tab. 2).
The analysis of 1954A > G ABCB4 polymorphism has 
shown that the homozygote 1954AA ABCB4 genotype and 
the heterozygote 1954AG ABCB4 genotype had similar fre-
quencies across the ICP and the control group (respectively: 
21.88% vs 17.54%, OR = 1.32, p = 0.23 and 78.12% vs 82.46%, 
OR = 0.76, p = 0.23). We have not observed the presence of 
a mutated homozygote 1954GG ABCB4 genotype in neither 
of the investigated groups. Similar observation applies to 
alleles’ frequency i.e., the presence of both alleles 1954A and 
1954G was similar in both investigated groups (for 1954A 
allele: 89.06 vs. 91.23%, OR = 0.78, p = 0.24, for 1954G allele: 
10.94 vs. 8.77%, OR = 1.28, p = 0.24) (Tab. 3).
Analysis of 1331T > C ABCB11  
and 1954A > G ABCB4 co-existence 
The cross-tabulation of genotype combinations of 
1331T > C ABCB11 and 1954A > G ABCB4 is displayed in 
Table  4. The higher frequency of genotypes containing 
2 mutated alleles for 1331T > C ABCB11 polymorphism 
was shown in ICP group then in controls: 1331CC/1954AA 
(31.25 vs. 25.12, p = 0.16) and 1331CC/1954AG (8.33 vs. 4.27, 
p = 0.12).
Table 2. The distribution of genotypes and alleles of ABCB11 gene 1331T > C polymorphism among women with ICP and controls
ABCB11
1331T > C
Study group ICP
(n = 96)
Control group 
(n = 211)
OR 95% CI p
Genotypes Observed value n (%)
Expected value 
[%]
Observed value 
n (%)
Expected value 
[%]
TT 11 (11.46) 12.92 38 (18.01) 19.64 0.59 0.29–1.21 0.10
TC 47 (48.96) 46.04 111 (52.61) 49.35 0.86 0.53–1.40 0.32
CC 38 (39.58) 41.04 62 (29.38) 31.01 1.57 0.95–2.61 0.05
Total 96 (100.00) 100.00 211 (100.00) 100.00
Alleles
T 69 (35.94) – 187 (44.31) – 0.71 0.50–1.00 0.03
C 123 (64.06) – 235 (55.69) – 1.42 1.00–2.02 0.03
Total 192 (100.00) – 422 (100.00) –
HWE: ICP p = 0.54; CONTROL p = 0.34
Table 3. The distribution of genotypes and alleles of ABCB4 gene 1954A > G polymorphism among women with ICP and controls
ABCB4
1954A > G
Study group ICP
(n = 96)
Control group 
(n = 211)
OR 95%CI p
Genotypes Observed value n (%)
Expected value 
[%]
Observed value 
n (%)
Expected value 
[%]
AA 75 (78.12) 79.32 174 (82.46) 83.23 0.76 0.42–1.38 0.23
AG 21 (21.88) 19.48 37 (17.54) 16.00 1.32 0.72–2.40 0.23
GG 0 (0.00) 1.20 0 (0.00) 0.77 – – –
Total 96 (100.00) 100.00 211 (100.00) 100.00
Alleles
A 171 (89.06) – 385 (91.23) – 0.78 0.44–1.38 0.24
G 21 (10.94) – 37 (8.77) – 1.28 0.73–2.25 0.24
Total 192 (100.00) – 422 (100.00) –
HWE: ICP p = 0.23; CONTROL p = 0.16
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DISCUSSION
1331T > C ABCB11 and 1954A > G ABCB4 
polymorphisms
Membrane transporters ABCB4 and ABCB11 are re-
sponsible for the removal of the bile acids from hepato-
cytes. Consequently, their mutated genetic variants may be 
involved in ICP etiology [9, 19]. The polymorphism that has 
received most attention is 1331T > C in the ABCB11 gene 
that encodes BSEP.
The role of 1331T > C polymorphism of the ABCB11 gene 
has been confirmed in our study. In the group of a total of 
96 women with ICP, we have observed a higher frequency of 
mutated homozygotic genotype 1331CC (39.58% vs 29.38%, 
OR = 1.57, p = 0.05) and a higher frequency of mutated 
1331C allele (64.06% vs. 55.69%, OR = 1.42, p = 0.03) when 
compared to ICP-free controls.
Other authors have obtained similar results. Meier et al. 
has shown a probable association between the 1331T > C 
ABCB11 gene polymorphism and the occurrence of ICP 
or contraceptive-induced cholestasis (CIC) (4 women with 
CIC, 41 with ICP, 205 healthy subjects, 40 healthy pregnant 
women). All women with CIC were carriers of the mutated 
1331C allele. The lowest TBA level was observed in patients 
with the 1331TT genotype and the highest in patients with 
the 1331CC genotype. The authors have concluded that 
a strong dysfunction of bile acid transporters BSEP caused 
by the presence of 1331CC ABCB11 genotype could lead 
to the development of cholestasis during oral contracep-
tion. It has also been revealed that the presence of 1331CT 
ABCB11 genotype could be a reason of developing ICP [9].
Interestingly, women from Asian populations who are 
known to have a lower incidence of ICP have also been 
suggested to develop the pathology in association with 
ABCB4 and ABCB11 gene polymorphisms. Kamimura et al. 
reports a first Japanese case of a pregnant women with ICP 
associated with 1331T > C (rs2287622, V444A) ABCB11 and 
504C > T (rs1202283, N168N) ABCB4 gene polymorphisms [20].
Many studies focus on a few polymorphisms at once. Was-
muth et al. has analyzed a few polymorphisms of ABCB4 and 
ABCB11 genes and its haplotypes in Swedish population 
(e.g. 1331T > C ABCB11 and 1954A > G ABCB4). In a sample 
of 45,485 pregnant women, 937 reported itching (2.1%), of 
which 693 were diagnosed with ICP (TBA ≥ 10 µmol/L) (1.5%) 
and 130 (0.3%) with a severe ICP (TBA ≥ 40 µmol/L). There 
were no differences as to the frequency of ABCB11 gene hap-
lotypes. Yet, some variants of ABCB4 gene haplotype have 
shown to be a risk factor for a severe ICP. The ABCB4_5 hap-
lotype in particular was observed more frequently in the 
study group (5.8% vs. 0.9%) [21].
In our study we have also analyzed a 1954A > G 
ABCB4 gene polymorphism in the ICP group. We have found 
no statistically significant difference in the frequency of 
genotypes and alleles. Similar observations are reported 
by Bacq et al. who have investigated 8 polymorphisms of 
ABCB4 gene that is involved in the MDR3 synthesis (50 wom-
en with ICP, 107 controls, Caucasian race). No correlation 
was found between 1954A > G ABCB4 gene polymorphism 
and the development of ICP. Yet, a statistically significant 
difference was revealed as to the frequency of Arg590Gln 
ABCB4 gene polymorphism, which was higher in the ICP 
group compared to the controls (p = 0.0017, OR = 16.03) [22].
Coexistence of 1331T > C ABCB11  
and 1954A > G ABCB4 gene polymorphism
Our study has also performed the analysis of coexistence 
of polymorphisms in ABCB4 and ABCB11 genes. Higher fre-
quency of coexistence of genotypes containing 2 mutated 
alleles of 1331T  > C ABCB11 polymorphism and 1954A > G 
variants of ABCB4 gene in ICP group was revealed. These 
observations are confirmed by other studies. For instance, 
Dixon et al. have investigated 6 genes involved in the eti-
ology of ICP by analyzing 83 polymorphisms in ABCB4, 
ABCB11, ABCC2, ATP8B1, NR1H4 and FGF19 gene. The ICP 
group consisted of 563 patients whereas the control group 
Table 4. The co-existence rate of the 1331T > C and the 1954A > G polymorphisms in the respective ABCB11 and ABCB4 genes of the studied groups
ABCB4 1954A > G Total
AA AG GG
Study group ICP
(n = 96)
ABCB11
1331T > C
TT 9 (9.38) 2 (2.08) 0 (0.00) 11 (11.46)
TC 36 (37.5) 11 (11.46) 0 (0.00) 47 (48.96)
CC 30 (31.25) 8 (8.33) 0 (0.00) 38 (39.58)
Total 75 (78.13) 21 (21.88) 0 (0.00) 96 (100.00)
Control group  
(n = 211)
ABCB11
1331T > C
TT 29 (13.74) 9 (4.27) 0 (0.00) 38 (18.01)
TC 92 (43.60) 19 (9.00) 0 (0.00) 111 (52.61)
CC 53 (25.12) 9 (4.27) 0 (0.00) 62 (29.38)
Total 174 (82.46) 37 (17.54) 0 (0.00) 211 (100.00)
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consisted of 642 healthy pregnant women, all of Cauca-
sian race. The study revealed that the key role in ICP etiology 
is played by the coexistence of polymorphisms of ABCB4 and 
ABCB11 genes [19, 23].
Anzivimo et al. arrive to similar conclusions (33 pregnant 
patients with ICP, Italian population). The authors have re-
vealed 5 new mutations (2 in ABCB4 gene: 1587DfsX603, 
1738LfsX744 and 3 in ABCB11 gene: V284D, Q558H, P731S). 
The most severe ICP was observed in carriers of I587DfsX603, 
I738LfsX744 and V284D mutations [24].
Such strong correlation of various dysfunctional genetic 
variants involved in the bile acid metabolism confirms the 
hypothesis that the impairment of bile transport present 
in ICP can be caused by a dysfunctional genetic variants, 
especially when in combination. In the course of ICP sud-
den intrauterine fetal demise may be observed. In turn, in 
severe ICP the frequency of intrauterine fetal demise is as 
high as 5.6% [21, 25–28].
CONCLUSIONS
Overrepresentation of mutated genetic variants of 
1331T > C ABCB11 in the ICP group suggests its role in 
the ICP etiology. The analysis of coexistence of the inves-
tigated polymorphisms shows the influence of 1954A > G 
ABCB4 and 1331T > C ABCB11 on the risk of ICP develop-
ment. Yet, there is a need to continue genetic studies on 
larger groups of patients.
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